1 |
Aln-cc5 |
- |
- |
- |
- |
062 [3] 62, 66, 109 💬 |
2 |
Alxn1210 |
- |
- |
- |
- |
002 [5] 2 , 11, 13, 62, 109 💬 |
3 |
Anti-c5 antibody |
- |
- |
- |
- |
011 [4] 11, 14, 62, 109 💬 |
4 |
Ccx168 |
- |
- |
- |
- |
043 [6] 43, 44, 66, 109, 222, 223 💬 |
5 |
Cemdisiran |
Cemdisiran |
- |
- |
- |
066 [2] 66, 109 💬 |
6 |
Coversin |
Nomacopan |
[1] D11473 D11473 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 [2] 62, 109 💬 |
7 |
Eculizumab |
Eculizumab |
[1] D03940 D03940 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
011 [8] 11, 13, 14, 61, 62, 109, 222, 223 💬 |
8 |
Fc- and cdr-modified humanised monoclonal antibody against c5 |
- |
- |
- |
- |
011 [3] 11, 62, 109 💬 |
9 |
Igg2/4? |
- |
- |
- |
- |
109 [1] 109 💬 |
10 |
Masp-2 antibody |
Narsoplimab |
[1] D11531 D11531 💬 |
MASP2 [1] MASP2 💬 |
Complement and coagulation cascades [3] Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
064 [2] 64, 109 💬 |
11 |
Oms00620646, oms620646, masp-2 antibody |
Narsoplimab |
[1] D11531 D11531 💬 |
MASP2 [1] MASP2 💬 |
Complement and coagulation cascades [3] Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
109 [1] 109 💬 |
12 |
Oms721 |
- |
- |
- |
- |
064 [3] 64, 66, 109 💬 |
13 |
Oms721 100 mg/ml injection solution, oms00620646, oms620646, masp-2 antibody |
Narsoplimab |
[1] D11531 D11531 💬 |
MASP2 [1] MASP2 💬 |
Complement and coagulation cascades [3] Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
064 [2] 64, 109 💬 |
14 |
Oms721 185 mg/ml injection solution, oms00620646, oms620646, masp-2 antibody |
Narsoplimab |
[1] D11531 D11531 💬 |
MASP2 [1] MASP2 💬 |
Complement and coagulation cascades [3] Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
064 [2] 64, 109 💬 |
15 |
Oms721 drug product 185 mg/ml |
- |
- |
- |
- |
109 [1] 109 💬 |
16 |
Other: eculizumab |
Eculizumab |
[1] D03940 D03940 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
109 [1] 109 💬 |
17 |
Ravulizumab |
Ravulizumab |
[1] D11054 D11054 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
002 [5] 2 , 11, 13, 62, 109 💬 |
18 |
Rva576 |
- |
- |
- |
- |
062 [3] 62, 109, 162 💬 |
19 |
Rva576 (coversin) |
Nomacopan |
[1] D11473 D11473 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 [2] 62, 109 💬 |
20 |
Solaris |
- |
- |
- |
- |
109 [1] 109 💬 |
21 |
Soliris |
- |
- |
- |
- |
011 [7] 11, 13, 14, 61, 62, 109, 222 💬 |
22 |
Soliris - 300 mg concentrato per soluzione per infusione - uso endovenoso 1 flaconcino (vetro) 30 ml (10 mg/ml) |
- |
- |
- |
- |
109 [1] 109 💬 |
23 |
Soliris 300 mg concentrado para solución para perfusión |
- |
- |
- |
- |
109 [1] 109 💬 |